ArticleBiomedicines2025

Secosteroid-2-Pyrazoline Hybrids: Design, Synthesis, Biological Evaluation and Development of Therapeutic Combinations Against ERα-Positive Breast Cancer Cells.

Alexey I Ilovaisky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.